The END Fund Chief Executive Officer Ellen Agler says that because of the coronavirus pandemic, her organization has put a pause on all mass drug distribution campaigns designed to prevent neglected tropical diseases.
In an interview with Devex President and Editor-in-Chief Raj Kumar, Agler described how The END Fund, a major NTD funder, recently received a proposal in one country to shift from a campaign approach to disease prevention to a door-to-door approach — an effort that would cost 20% more.
For more on the future of NTD eradication in the wake of the COVID-19 pandemic, tune in to the complete interview.
More interviews with humanitarian leaders on COVID-19. Watch:
• Peter Sands' 'nightmare' coronavirus scenario
• Rockefeller Foundation’s pandemic chief calls for ‘herd awareness’
• UNAIDS director warns of 'colliding epidemics'
• InterAction's CEO on the pandemic's financial impact on NGOs
Visit our dedicated COVID-19 page for news, job opportunities, and funding insights.